Insiders ABIONYX Pharma

Equities

ABNX

FR0012616852

Real-time Euronext Paris Other stock markets 11:13:15 2024-04-30 am EDT			5-day change	1st Jan Change
1.05 ^EUR	+2.74%		-0.57%	-18.48%

Mar. 14	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
Mar. 11	Abionyx: reduced net loss in 2023	CF

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abionyx: former AbbVie executive appointed CMO	Jan. 09	CF
ABIONYX Pharma Appoints Rob Scott as Chief Medical Officer and Head of R&D	Jan. 08	CI
Abionyx: appointment of a chief digital & innovation officer	23-07-13	CF
Abionyx Pharma Names Digital, Innovation Chief	23-07-13	MT
Abionyx Pharma Names IRIS Pharma Founder as Chief Scientific Officer Amid Purchase Agreement	21-11-18	MT
ABIONYX Pharma : Announces a Named Patient Temporary Authorization for Use (ATUn) for CER-001 in France	20-01-08	BU
ABIONYX Pharma SA Announces Named Patient Temporary Authorization for Use for CER-001 in France	20-01-08	CI
ABIONYX Pharma SA Announces the Resignation of Barbara Yanni from Her Position as Member of the Board of Directors	20-01-03	CI
Cerenis Therapeteutics Holding will Change its Name to ABIONYX Pharma SA	19-09-16	CI
ABIONYX Pharma SA Announces Resignation of Richard Pasternak as Director and Chairman	19-09-13	CI
ABIONYX Pharma SA Announces Executive Changes	19-09-09	CI
Cerenis Therapeutics Holding SA will Change its Name to CERENIS Therapeutics	19-08-29	CI
ABIONYX Pharma Approves Appointment of Emmanuel Huynh as a Member of the Board	19-08-26	CI
Cerenis Therapeutics Holding SA Announces Executive Changes	18-12-19	CI
Cerenis Therapeutics Announces Appointment of Barbara Yanni to Board of Directors	18-08-07	CI
Cerenis Therapeutics Appoints Barbara Yanni as Independent Director	18-07-31	CI
Cerenis Therapeutics Holding SA Announces Appointment to Scientific Advisory Board	18-05-02	CI
Cerenis Therapeutics Announces Board Appointments	15-06-08	CI
Cerenis Therapeutics Announces Executive Changes	15-02-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer